23andMe CEO Wojcicki Says FDA Approval Is 'Huge Step Forward'

The transcript discusses the impact and future of a prize, comparing it to the Nobel Prize. It highlights personal excitement about genetics, physics, and the role of scientists as role models. The FDA's approval of genetic tests by 23andMe is seen as a significant step forward in pharmacogenomics, despite controversies and regulatory challenges. The political environment's impact on science and the importance of voting are also discussed.

What is the speaker's perspective on the public's understanding of drug interactions and genetic factors?

What does the speaker hope for the future of drug labeling in relation to pharmacogenetics?

What role does the speaker believe 23andMe plays in the landscape of genetic testing?

How does the speaker view the current political climate's impact on scientific research?